Ocular immunology and inflammation
-
Ocul. Immunol. Inflamm. · Jun 2016
Intravitreal Adalimumab in Active Noninfectious Uveitis: A Pilot Study.
To evaluate the short-term efficacy of intravitreal adalimumab (IVA) for the treatment of eyes with active noninfectious uveitis. ⋯ IVA was effective in controlling the inflammation, decreasing the macular edema, and improving the best corrected visual acuity in the majority of eyes in this series.